Respiratory Disorders Non-invasive Monitoring of Work of Breathing in Outpatients

Sponsor
Stanford University (Other)
Overall Status
Completed
CT.gov ID
NCT04003415
Collaborator
Work of Breathing Study Group (Other)
12
1
1
18.7
0.6

Study Details

Study Description

Brief Summary

This study will test the accuracy of an investigational, non-invasive device for measuring heart rate and respiratory rate. The device emits radiowaves that allows it to pick up subtle changes in a person's chest wall, which allows it to calculate the heart rate and respiratory rate. We propose to study whether the device's measurements are accurate and reproducible in patients with chronic obstructive pulmonary disease (COPD) or asthma. The device undergoing study has been evaluated in healthy volunteers, but its accuracy in vital sign monitoring in patients with respiratory conditions has not yet been established. This study will serve as the foundation for additional work to assess the device's accuracy in measuring a patient's overall "work of breathing" or respiratory effort. Future work will examine the device's accuracy in measuring work of breathing in patients having an exacerbation of their underlying respiratory condition.

The primary aim of this study will be to assess the validity of heart rate and respiratory rate measurements in patients with either COPD or asthma.

Condition or Disease Intervention/Treatment Phase
  • Device: Investigational Device: Contactless heart rate and respiratory rate monitor
  • Diagnostic Test: Heart Rate (EKG) Monitor
  • Diagnostic Test: Respiratory rate Monitor
  • Diagnostic Test: Pulse Oximetry
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
12 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
All participants enrolled in the study will be in the intervention arm. Intervention consists of device feasibility and validation of heart rate and respiratory rate data collected.All participants enrolled in the study will be in the intervention arm. Intervention consists of device feasibility and validation of heart rate and respiratory rate data collected.
Masking:
None (Open Label)
Primary Purpose:
Device Feasibility
Official Title:
Respiratory Disorders Non-invasive Monitoring of Work of Breathing in Outpatients
Actual Study Start Date :
Mar 1, 2020
Actual Primary Completion Date :
Sep 20, 2021
Actual Study Completion Date :
Sep 20, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Investigational Device Arm

Once consented for the study, participants will undergo testing with the investigational device for a one hour period. Testing will entail the participant wearing an EKG monitor, a respiratory rate monitor, a pulse oximeter, and being positioned next to the investigational device. The investigational device is contactless and captures chest movement of participants which allows it to estimate real time heart rate and respiratory rate. Additional data collected with the EKG monitor, respiratory rate monitor, and the pulse oximeter will be used to validate the vital sign data collected by the investigational device. After data collection is complete, participant involvement will then be over. Participants will have the option to return on a later date for additional testing (up to a maximum of three sessions total), within the six month window of the study. Participants will continue their standard of care therapies for their respiratory condition.

Device: Investigational Device: Contactless heart rate and respiratory rate monitor
Participant will be seated next to the investigational device. The device is contactless, and will measure the patient's heart rate and respiratory rate through use of radio-waves.
Other Names:
  • Investigational Device
  • Diagnostic Test: Heart Rate (EKG) Monitor
    Participant will undergo 3-lead EKG testing to measure heart rate during testing.

    Diagnostic Test: Respiratory rate Monitor
    Participant will have an elastic band around their chest for monitoring respiratory rate during testing.

    Diagnostic Test: Pulse Oximetry
    Participants will wear a finger pulse oximeter during the testing for monitoring of heart rate, respiratory rate, and pulse oximetry.

    Outcome Measures

    Primary Outcome Measures

    1. Heart Rate [30 - 60 minutes]

      Heart rate data as compared between the investigational device, a 3-lead EKG, and a finger probe.

    2. Respiratory rate [30 - 60 minutes]

      Respiratory rate data as compared between the investigational device, a respiratory rate monitor, and a finger probe.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patient seen at the Stanford University Hospital Chest Clinic

    • Patient age 18 or older

    • Patient able to consent

    • Patient with one of the following two medical conditions: Chronic Obstructive Pulmonary - Disease or Asthma

    • Participant (or accompanying family / caretaker) able to speak English

    Exclusion Criteria:
    • Patient does not meet inclusion criteria (under age 18, unable to consent, etc.)

    • Patient is hospitalized

    • Patient is having an acute exacerbation of their respiratory condition

    • Patient is having an acute exacerbation of a comorbid condition

    • Patient has comorbid cardiac disease, including one of the conditions listed below:

    • Arrhythmias (including atrial fibrillation, NSVT, etc.)

    • Congestive Heart Failure

    • Unstable angina

    • Myocardial infarction within the last 3 months prior to enrollment

    • Uncorrected congenital heart disease

    • Uncorrected severe valvular disease

    • Pulmonary Hypertension (moderate or higher grade)

    • Patient has one of the following conditions:

    • Moderate pleural effusion

    • Large pleural effusion

    • Advanced stage lung cancer (Stage III or Stage IV disease)

    • Active infectious process, including viral process or pneumonia

    • Interstitial lung disease

    • Pleural disease, including pleural malignancies, trapped lung, etc

    • Active Cheyne-Stokes respiration

    • Patient has baseline increased work of breathing not due to their underlying respiratory disease (ie. COPD or asthma)

    • Ongoing substance abuse (not including cigarette use)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Stanford University Palo Alto California United States 94304

    Sponsors and Collaborators

    • Stanford University
    • Work of Breathing Study Group

    Investigators

    • Principal Investigator: Andrea Jonas, Stanford University

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    Responsible Party:
    Andrea Jonas, Pulmonary & Critical Care Fellow, Stanford University
    ClinicalTrials.gov Identifier:
    NCT04003415
    Other Study ID Numbers:
    • IRB-51805
    First Posted:
    Jul 1, 2019
    Last Update Posted:
    Sep 28, 2021
    Last Verified:
    Sep 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 28, 2021